|
Corticosteroid Clinical Trials
4 actively recruiting trials across 4 locations
▲ +1 trial since May 2026
Also known as: Systemic corticosteroid, dexamethasone, methylprednisolone
Pipeline
Phase 2: 2Phase 4: 1Phase 1/2: 1
Top Sponsors
- Vanderbilt University Medical Center1
- Merck Sharp & Dohme LLC1
- Baptist Health South Florida1
- Aurinia Pharmaceuticals Inc.1
Los Alamitos, California1 trial
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Valerius Medical Group & Research Center of Greater Long Beach, Inc.
Phase 4
Miami, Florida1 trial
Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases
Miami Cancer Institute at Baptist Health, Inc.
Phase 1/2
Lexington, Kentucky1 trial
A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
University of Kentucky Chandler Medical Center ( Site 0019)
Phase 2
Nashville, Tennessee1 trial
Treating Exacerbations of Asthma With Oral Montelukast in Children
Monroe Carell Jr. Children's Hospital at Vanderbilt
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.